← Back to Search

Behavioural Intervention

System-level Tobacco Treatment Intervention for Smoking Cessation

N/A

Waitlist Available

Led By Mary E Cooley, PhD, RN

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have an actual or potential diagnosis of thoracic malignancy

Age ≥ 18

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will study how well a program called CEASE works to help people quit smoking who have lung cancer.

Who is the study for?

This trial is for current or recent smokers (within the last 6 months) who are over 18, can read and write in English, and have or might have lung-related cancer. It's not for those who quit smoking more than 6 months ago or have urgent health issues like severe breathing problems, very low blood pressure, confusion from high calcium levels, or dehydration.Check my eligibility

What is being tested?

The study is testing how well a program called CEASE works when it's added to usual care that helps people stop smoking in a lung cancer treatment setting. Researchers will use different methods to see how effective this integration is compared to the standard support services.See study design

What are the potential side effects?

Since this trial focuses on implementing a tobacco treatment intervention rather than medication, there may be no direct side effects like with drugs. However, participants may experience stress or discomfort related to quitting smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I may have or have been diagnosed with a chest cancer.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Smoking cessation Rate

Secondary outcome measures

Documentation of tobacco treatment

Trial Design

5Treatment groups

Experimental Treatment

Active Control

Group I: After Cease Implementation Aim 2Experimental Treatment1 Intervention

50 Current or former smokers (3 months +/-2 month) Tobacco Use Survey (Baseline,1- 6 Months) Biochemical verification

Group II: Cease-Aim 1Active Control1 Intervention

Cease Implementation 100 Patients after CEASE Implementation Exit Interview and Tobacco Use Survey

Group III: Pre Cease Implementation Aim 2Active Control1 Intervention

50 Current or former smokers (3 months +/-2 month) patients in usual care (before CEASE implementation) Tobacco Use Survey (Baseline,1- 6 Months) Biochemical verification

Group IV: Usual Care-Aim 1Active Control1 Intervention

Usual Care Tobacco Treatment Services 100 patients in usual care Exit Interview and Tobacco Use Survey

Group V: Clinician and Staff SurveyActive Control1 Intervention

- Interview clinicians and support staff (40)

0 / 2Eligibility criteria met